This article analyzes the state of current treatment options and highlights recent advancements in illness diagnosis and staging, developing disease biomarkers, and relapse/refractory disease treatment. Clinical professionals should use testis cancer treatment algorithms carefully in order to maximize long-term survival and quality of life as well as short-term, disease-related results.